James Swan is a Dermatology physician affiliated with Loyola University Medical Center. OpenAlex indexes 34 publications with 541 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2160 S 1st Ave
(321 Lagrange Rd., Lagrande Park, Il.60526)
Maywood, IL 601533328
Telephone
708-485-1020Registry record last updated 5 Mar 2010.
Clinical trials
- Preliminary Study of Peel Force and Discomfort of Removal of Adhesive Barriers in Normal and Peristomal Skin
Sponsor: Hollister Incorporated
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
32.5%Corticosteroid32.5%Betamethasone Dipropionate51%Clobetasol Propionate49%Part D<11 patientsDermatology
18.4%Corticosteroid18.4%Triamcinolone Acetonide100%Part D≥15 patientsCancer & immunology
13.5%TNF inhibitor13.5%Enbrel Sureclick50%Humira(Cf) Pen50%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Unilateral Grover-like Skin Eruption Following Pfizer COVID-19 Vaccine
American Journal of Dermatopathology
2023 - Psychiatric Comorbidity in Prurigo Nodularis and the Impact of Socioeconomic Status.
PubMed
2022 - 237 Psychiatric comorbidity in prurigo nodularis and the impact of socioeconomic status
Journal of Investigative Dermatology
2021 - Verifying Death Reports in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
American Journal of Therapeutics
2020 - High Prevalence of Erythrasma in Patients with Inverse Psoriasis: A Cross-sectional Study.
PubMed
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Patrick Stiff, MD
Loyola University Medical Center
Olufemi Kassim, MD
Loyola University Medical Center
Jose Biller, MD
Loyola University Medical Center
Kathy Albain, MD
Loyola University Medical Center
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”